We similarly detected SERT expression using immunohistochemistry (IHC) in sections of patient-derived breast tumor xenografts (PDX), which mimicked the histopathology of the primary tumors from which they were derived, and comprised each of the major clinical subtypes of breast cancer (Figure 4). The gene discussed is SLC6A4; the disease is breast neoplasm.